BIVI logo

BioVie (BIVI) Company Overview

Profile

Full Name:

BioVie Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 18, 2020

Indexes:

Not included

Description:

BioVie Inc. (BIVI) is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. Their research aims to improve the lives of patients with conditions like Alzheimer's and Parkinson's by creating new therapies that target underlying causes of these diseases.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 11, 2025

Recent annual earnings:

Aug 6, 2020
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 6, 2024

Analyst ratings

Recent major analysts updates

Jul 1, 24 ThinkEquity
Buy
Nov 30, 23 Oppenheimer
Outperform
Aug 22, 23 Cantor Fitzgerald
Overweight
Jul 18, 23 Cantor Fitzgerald
Overweight
May 17, 23 Oppenheimer
Outperform
May 17, 23 Cantor Fitzgerald
Overweight
Feb 14, 23 Oppenheimer
Outperform
Sep 28, 22 EF Hutton
Buy
Jul 22, 22 Cantor Fitzgerald
Overweight
Mar 17, 22 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for BioVie?
  • Does BioVie pay dividends?
  • What sector is BioVie in?
  • What industry is BioVie in?
  • What country is BioVie based in?
  • When did BioVie go public?
  • Is BioVie in the S&P 500?
  • Is BioVie in the NASDAQ 100?
  • Is BioVie in the Dow Jones?
  • When was BioVie's last earnings report?
  • When does BioVie report earnings?
  • Should I buy BioVie stock now?

What is the ticker symbol for BioVie?

The ticker symbol for BioVie is NASDAQ:BIVI

Does BioVie pay dividends?

No, BioVie does not pay dividends

What sector is BioVie in?

BioVie is in the Healthcare sector

What industry is BioVie in?

BioVie is in the Biotechnology industry

What country is BioVie based in?

BioVie is headquartered in United States

When did BioVie go public?

BioVie's initial public offering (IPO) was on September 18, 2020

Is BioVie in the S&P 500?

No, BioVie is not included in the S&P 500 index

Is BioVie in the NASDAQ 100?

No, BioVie is not included in the NASDAQ 100 index

Is BioVie in the Dow Jones?

No, BioVie is not included in the Dow Jones index

When was BioVie's last earnings report?

BioVie's most recent earnings report was on Feb 11, 2025

When does BioVie report earnings?

The next expected earnings date for BioVie is May 14, 2025

Should I buy BioVie stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions